- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Venus Remedies Limited — Important, 22-05-2025: Updates
22-05-2025 | 10:01 am
22-05-2025 | 10:01 am
Venus Remedies has announced a board meeting to review the financial results for the quarter and half-year. The company renewed its Ukrainian GMP certification for its Baddi plant, covering cephalosporin, carbapenem, and oncology injectables. This boosts its presence in Ukraine and expands access to 32 Plc/S countries, reinforcing its global growth focus in generics and oncology, with strong capabilities in antimicrobial resistance products.
No comments yet. Be the first to comment!